Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
May-2016 Volume 4 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2016 Volume 4 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Effect of the Fructus Ligustri Lucidi extract and its monomers quercetin and oleanolic acid on the adhesion and migration of melanocytes and intracellular actin

  • Authors:
    • Yanhua Wu
    • Qilin Li
    • Xiangjun Li
    • Danhua He
    • Mu Niu
    • Xiaojuan Lu
    • Hui Li
  • View Affiliations / Copyright

    Affiliations: Department of Dermatology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou, Guangdong 510220, P.R. China
  • Pages: 583-588
    |
    Published online on: March 23, 2016
       https://doi.org/10.3892/br.2016.638
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study aimed to investigate the effects of the Fructus Ligustri Lucidi (FLL) extract and its monomers quercetin and oleanolic acid on the adhesion and migration of human epidermal melanocytes (MCs) and intracellular actin. The human epidermal MCs were cultured and identified. The cells were treated with different concentrations of FLL extract, quercetin and oleanolic acid. The adhesion and migration abilities of the cells were determined by the fibronectin‑coated culture experiment and Transwell assay, respectively. The structure and distribution of intracellular actin were observed by confocal laser microscopy, with semi-quantitative analysis. Results showed that compared with the control group, 0.0375‑0.3 mg/ml of the FLL extract and 40 µM quercetin significantly improved the adhesion rate of MCs (P<0.05). The numbers of MCs permeating the microporous membrane in the 0.15 mg/ml FLL extract and 12 µM oleanolic acid groups were 43.7 and 30.3, respectively, significantly higher compared to the control group (P<0.01). In the control group, the intracellular actin was less, and the stress fiber structure was not clear. In the 0.15 mg/ml FLL extract, 12 µM oleanolic acid and 40 µM quercetin groups, there were numerous bunched stress fibers, indicating the aggregation of filamentous fibrous actin. The mean optical densities of actin expression in the 0.15 mg/ml FLL extract, 12 µM oleanolic acid and 40 µM quercetin groups were significantly higher compared to the control group (P<0.05). The FLL extract has a significant stimulatory effect on the adhesion and migration of human epidermal MCs. The mechanism may be associated with the promotion of intracellular actin cytoskeleton aggregation.

Introduction

A previous study has shown that the disequilibrium of the microenvironment in melanocytes (MCs) and the regression of cell adhesion and migration, which are caused by psychological, nerve and immunity factors, are the main pathogeneses of vitiligo (1). In the initial effective stage of vitiligo treatment, the pigmentation occurs from the hickie follicular orifice, and extends to be flakiness. There are amelanotic melanocytes (AMMCs) in the hair follicle outer root sheath, which are the most important MC reservoir for skin lesion repigmentation (2). During the repigmentation course, MCs experience the stage of activation, migration, adhesion and proliferation (3). The dynamic equilibrium of aggregation and disaggregation of actin cytoskeleton is the important regulating factor for cell adhesion and migration.

Fructus Ligustri Lucidi (FLL), as a member of Chinese herbs, has an important role in the treatment of disease. The active ingredients of FLL include oleanolic acid, butyl alcohol, tyrosol, quercetin, palm acid, stearic acid, polysaccharide, oleic acid, flax and linum (4). Quercetin and oleanolic acid are two most important monomers of FLL extract. Oleanolic acid has the anti-inflammatory, antimutagenic, antioxidant, anti-virus and liver protection activity (5,6). Quercetin has the function of antioxidation, anti-inflammation, lowering blood pressure, anti-platelet aggregation, antitumor, anti-atherosclerosis and regulating immunity (7–9). Previous studies have reported that the FLL extract and its monomers oleanolic acid and quercetin can improve the tyrosinase activity of MCs, and stimulate the melanogenesis (10–14). However, their effects on adhesion, migration of MCs and the intracellular actin are seldom reported. In the present study, the effects of the FLL extract and its monomers oleanolic acid and quercetin on the adhesion and migration of human epidermal MCs and intracellular actin were investigated, and the associated mechanism was discussed. The aim was to provide a basis for further application of FLL to treatment of vitiligo.

Materials and methods

Materials

The FLL extract was prepared by ethanol extraction from FLL (China's National Institute for the Control of Pharmaceutical and Biological Products, Beijing, China). FLL was soaked in 10 ml of 90% ethanol (Sigma-Aldrich, St. Louis, MO, USA) for 1 week at room temperature. Following filtration, the extraction solution was obtained. The ethanol was removed by concentration, and the cream mixture was obtained. The 200 mg/ml ethanol solution of the FLL extract was prepared. Using fresh M254 medium (Fuzhou Maixin Biotechnology Development Co., Ltd., Fuzhou, China), the concentration of the FLL extract was adjusted to 0.6, 0.3, 0.15, 0.075 and 0.0375 mg/ml, respectively. Quercetin and oleanolic acid were provided by China's National Institute for the Control of Pharmaceutical and Biological Products. The concentration of quercetin was adjusted to 80, 40, 20, 10 and 5 µM, respectively, and the concentration of oleanolic acid was adjusted to 24, 12, 6, 3 and 1.5 µM, respectively.

Culture and identification of MCs

The circumcision specimens were obtained from 10–25-year-old normal adolescent males who underwent circumcision in the Department of Urology (The Fourth Affiliated Hospital of Jinan University, Guangzhou Red Cross Hospital, Guangzhou, Guangdong, China). The patients had no history of pigmentation disorder such as vitiligo. The study was approved by the ethics committee of the Fourth Affiliated Hospital of Jinan University. Written informed consent was obtained from the patients. The circumcision specimens were soaked in 70% alcohol for 5–10 min, followed by rinsing with phosphate-buffered saline (PBS; Sigma-Aldrich) 6–12 times. The specimens were transferred to the sterile petri dish containing a small amount of PBS. The dermis and subcutaneous fatty tissue were removed. The remaining specimens were separated into square pieces (2×2 mm), and tiled in the sterile petri dish. 0.25% Dispase II (Fuzhou Maixin Biotechnology Development Co., Ltd.) was added for digestion at 4°C for 16–24 h, followed by incubation at 37°C for 1 h. The epidermis was separated and was washed with PBS 3–5 times. Following digestion for 5 min, M254 complete medium containing 10% fetal calf serum (Fuzhou Maixin Biotechnology Development Co., Ltd.) was added to terminate digestion. The MCs were pipetted from the epidermis, and the cell suspension was obtained, followed by filtering with a 200-mesh sieve (Fuzhou Maixin Biotechnology Development Co., Ltd.). Following centrifugation at 225 × g for 3 min, cell counting was performed. After 24 h of culture using M254 culture medium (Fuzhou Maixin Biotechnology Development Co., Ltd.), the first culture medium was changed, followed by a change of culture medium every 3 days. After primary culture for 8–15 days, the MCs were 80% confluent. The cells were inoculated to the new sterile flasks for continued culture. The 3–5 generation of MCs were used for further experiments.

MCs were identified by the L-DOPA staining and HMB-45 immunochemical staining method. For the former method, the cell climbing slice was prepared and was fixed with 4% paraformaldehyde (Sigma-Aldrich) for 25 min. The slice was incubated in L-DOPA staining solution (Shanghai Sangon Biological Engineering Co., Ltd., Shanghai, China) for 4 h, followed by washing with water for 5 min. For the latter method, the cell climbing slice was fixed with 4% paraformaldehyde for 25 min, followed by washing with PBS for 5 min. The mouse anti-human HMB-45 monoclonal antibody (cat no. SG7870; used 1:50; Shanghai Sangon Biological Engineering Co., Ltd.) was used as the primary antibody, and the anti-mouse IgG-HRP (cat no. SC2023; used 1:500; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) was used as the secondary antibody. The diaminobenzidine coloration, counterstain, dehydration, transparency and mounting were performed according to the manufacturer's protocol. PBS replacing the primary antibody was used as the negative control.

Determination of cell proliferation activity with the XTT assay

MCs were inoculated in 96-well plates (5×104 cell/ml), 100 µl for each well, followed by culture for 24 h. The complete culture medium containing different concentrations of the drugs was added. The culture medium without the drug was used as the control. After culture for 24, 48 and 72 h, the cell morphology was observed under a DVM6 optical microscope (Leica Science Lab, Berlin, Germany). XTT/PMS solution (50 µl; Sigma-Aldrich) was added to the well, followed by incubation at 37°C for 4 h. The absorbance value was determined at 490 nm. The concentration without any cytotoxicity was selected for the cell adhesion and migration determination assays.

Determination of cell adhesion

MCs were cultured with complete culture medium containing different concentrations of the drugs for 3 days. M254 medium (50 µl) containing 20 µg/ml fibronectin (Shanghai Sangon Biological Engineering Co., Ltd.) was added to each well, followed by incubation at 37°C for 24 h. Following washing with PBS, the cells were inoculated in 96-well plate coated with fibronectin (5×105 cell/ml), followed by incubation at 37°C for 4 h. MCs without drug treatment were used as the control. The cells without adhesion were rinsed with PBS, and subsequently 50 µl XTT/PMS solution was added to the well, followed by incubation at 37°C for 4 h. The absorbance value (A) was measured at 490 nm. The cell adhesion rate was expressed as (A490treatment group/A490control group) × 100.

Determination of cell migration

The Transwell microporous membrane was coated with fibronectin (20 µg/ml), followed by drying in the super-clean bench overnight and washing with PBS. The MCs [100 µl of 2×105 cell/ml, diluted with M254 medium containing 0.1% bovine serum albumin (BSA)] were added to the upper chamber and 500 µl complete medium containing different drugs was added to the lower chamber. The complete medium without drugs was used as the control. After culture for 24 h, the chamber was removed and the cells in the upper chamber surface were grazed by a swab. The cells in the lower chamber were fixed with 4% paraformaldehyde (Sigma-Aldrich) for 30 min. The membrane was cut using an operating knife blade, followed by hematoxylin and eosin staining for 10 min. Three visual fields were randomly selected under a microscope, and the MCs migrating to the lower membrane were counted.

Observation of structure and distribution of actin in MCs

MCs were cultured with complete culture medium containing drugs for 3 days. MCs without drug treatment were used as the control. The density of the cells was adjusted to 2×104 cell/ml. The cell climbing slices were prepared, followed by fixation with paraformaldehyde. Following rupture of the membrane at room temperature using 0.1% Triton X-100/PBS (Fuzhou Maixin Biotechnology Development Co., Ltd.), the cells were blocked using PBS containing 1% BSA for 30 min. Fluorescein isothiocyanate-phalloidin (5 µg/ml; Fuzhou Maixin Biotechnology Development Co., Ltd.) was added, followed by staining at room temperature for 30 min. Following fluorescence mounting, the slices were observed with an FV1200 confocal laser scanning microscopy (Olympus Corp., Tokyo, Japan) at 488 nm. Three visual fields were randomly selected for semiquantitative analysis fluorescence intensity. The mean optical density (MOD) was expressed as total cell integral optical density/total cell area.

Statistical analysis

All the statistical analyses were carried out using SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). Data are presented as mean ± standard deviation. Comparisons between two groups were performed using Student's t-test. P<0.05 was considered to indicate a statistically significant difference.

Results

Culture and identification of normal MCs

Following culture, the adherent MCs presented slender dendrites, with fusiform shape or polygon shape. The proportion of caryon to endochylema was large. There was strong halation around the cell body caused by refraction, and the cells were reticulated. Following L-DOPA staining, the endochylema and dendrite presented brown or black (positive staining) (Fig. 1A). The HMB-45 immunocytochemical stain was brown, which indicated that the mature MCs had the function of synthesizing melanin (Fig. 1B).

Figure 1.

Staining of the melanocytes. (A) L-DOPA staining (magnification, ×200) and (B) HMB-45 immunocytochemical staining (magnification, ×200).

Cytotoxicity

The result of the XTT assay showed that 0.0375–0.3 mg/ml of the FLL extract, 5–40 µM quercetin and 1.5–12 µM oleanolic acid had no evident cytotoxicity to MCs. The 0.15 mg/ml FLL extract, 40 µM quercetin and 12 µM oleanolic acid did not evidently promote cell proliferation in 24 h (P>0.05), and these concentrations were selected for the cell migration experiment.

Effects of the FLL extract, quercetin and oleanolic acid on the adhesion of MCs

Compared with the control group, 0.0375–0.3 mg/ml of the FLL extract significantly improved the adhesion rate of MCs (P<0.05) in a dose-dependent manner. When the concentration researched 0.6 mg/ml, the adhesion rate descended, which may be caused by cytotoxicity due to a high drug concentration. Quercetin at 40 µM also significantly improved the adhesion rate compared with the control group (P<0.05). However, no significance difference was identified between each oleanolic acid group and control group (P>0.05) (Table I).

Table I.

Effect of the FLL extract, quercetin and oleanolic acid on the adhesion rate of melanocytes.

Table I.

Effect of the FLL extract, quercetin and oleanolic acid on the adhesion rate of melanocytes.

GroupConcentrationAdhesion rate, %
Control0100.00
FLL extract, mg/ml0.0375 119.60±11.70a
0.0750 130.80±14.79a
0.1500 142.70±14.23b
0.3000 153.43±19.48b
0.6000 125.63±15.56a
Quercetin, µM  588.93±9.93
1098.33±17.40
20110.70±23.29
40 133.97±13.02a
Oleanolic acid, µM1.594.37±11.58
  3108.59±14.12
  698.30±10.91
12114.93±22.11

a P<0.05 and

b P<0.01 compared with control group. FLL, Fructus Ligustri Lucidi.

Effects of the FLL extract, quercetin and oleanolic acid on the migration ability of MCs

The number of MCs permeating the microporous membrane in the 0.15 mg/ml FLL extract and 12 µM oleanolic acid groups were 43.7 and 30.3, respectively, which were significantly increased compared with the control group (P<0.01). The number of cells permeating the microporous membrane in the 40 µM quercetin group was 23.3, and no significant difference was identified when compared with the control group (P>0.05) (Fig. 2).

Figure 2.

Effects of the FLL extract, quercetin and oleanolic acid on migration of melanocytes (magnification, ×200). (A) Control; (B) 0.15 mg/ml FLL extract; (C) 12 µM oleanolic acid; and (D) 40 µM quercetin. FLL, Fructus Ligustri Lucidi.

Effects of the FLL extract, quercetin and oleanolic acid on the structure and distribution of actin in MCs

In the control group, the fluorescence density was low and was uniformly and sparsely distributed. This indicated that the intracellular actin was less, and the stress fiber structure was not clear. The fluorescence in the 0.15 mg/ml FLL extract, 12 µM oleanolic acid and 40 µM quercetin groups was mainly distributed around the inner side of the cell membrane and caryon, and numerous bunched stress fibers could be observed. This indicated that there was an aggregation of filamentous fibrous actin (Fig. 3). The MOD of actin expression in the 0.15 mg/ml FLL extract, 12 µM oleanolic acid and 40 µM quercetin groups was higher compared to the control group (P<0.05) (Fig. 4).

Figure 3.

Effects of the FLL extract, quercetin and oleanolic acid on actin structure distribution in melanocytes (magnification, ×600). (A) Control; (B) 0.15 mg/ml FLL extract; (C) 12 µM oleanolic acid; and (D) 40 µM quercetin. FLL, Fructus Ligustri Lucidi.

Figure 4.

Effects of the FLL extract, quercetin and oleanolic acid on the mean optical density of actin expression in melanocytes. Group 1, control; group 2, 0.15 mg/ml FLL extract; group 3, 12 µM oleanolic acid; and group 4, 40 µM quercetin. FLL, Fructus Ligustri Lucidi.

Discussion

The present study investigated the effects of the FLL extract and its monomers oleanolic acid and quercetin on the adhesion and migration of MCs and the structure and distribution of intracellular actin. The results show that the FLL extract has a significant stimulatory effect on the adhesion and migration of MCs. Quercetin can promote the adhesion of MCs and oleanolic acid can induce the migration of MCs. Liu et al (10) reported that the FLL extract can improve the tyrosinase activity of MCs. The study by Chang et al (11) shows that the FLL extract can significantly promote the proliferation of B10BR MCs, which indicates that the treatment of vitiligo using the FLL extract may be associated with its promotion of keratinocyte secreting cytokine, and a change of the epidermic microenvironment. Zhang et al (12) identified that oleanolic acid can increase the expression levels of MC tyrosinase and tyrosinase-related protein 1 (TRP-1) mRNA, and improve the activity of tyrosinase and melanin synthesis. In addition, oleanolic acid can promote the proliferation of MCs. Takeyama et al (13) studied the influence of quercetin on melanin formation in MCs and reported that quercetin can induce the increase of tyrosinase activity of epidermic cells and increase the melanin content. In addition, the ultrastructure study shows that following quercetin treatment, more mature melanosomes assemble at the stratum basale MC with extended cell dendrites. The study by Nagata et al (14) observed that quercetin can improve the tyrosinase activity of in vitro-cultured melanoma cells and normal MCs, increase the synthesis of melanin and decrease the level of other melanin formation inhibitors. In addition, the activation of tyrosinase by quercetin can be blocked by actinomycin-D and cycloheximide, which indicates that quercetin can regulate the transcription and translation level for melanin formation. Nylander et al (15) reported that tyrosinase and TRP-1 can be activated by P53 albumen associated with ultraviolet ray. Quercetin can activate P53 albumen, so it is presumed that upregulation of melanin synthesis by quercetin is due to its promotion of P53 albumen activation (16). The aforementioned studies have provided evidence for further application of the FLL extract, oleanolic acid and quercetin to the clinical treatment of vitiligo.

During the repigmentation in vitiligo treatment, the pigment island appears firstly on the follicular orifice of leukoplakia, and subsequently extends to be flakiness. The pigment is the darkest on the follicular orifice, and is the lightest on the recovering zone. A previous study has reported that there are HMB-45, TYR, TRP1 and TRP2-negative AMMCs in the hair follicle outer root sheath (17). In this position AMMCs are not damaged, and are activated by the specificity factors. They move to the epidermis and extend outward from the follicular orifice, for pigment regeneration. AMMCs are the most important reservoir in the course of pigment regaining (2). Another study has shown that the activation and adhesion of AMMCs in the hair follicle outer root sheath and their migration to the lesion position is key for regaining pigment (18).

Cell adhesion and migration is an initiative course of consuming energy, which requires cytoskeleton participation. The main components of the cytoskeleton are the microtubule, microfilament and intermediate filament. The microfilament can form a stress fiber. The fibrous actin is formed by polymerization of the monomer globular actin. Actin is the most important structural component of lamellar pseudopodium of motor cells. The review by Miao (19) reported that following treatment with cytochalasin D, a drug which can specifically inhibit the polymerization of actin cytoskeleton, the oriented movement of cells is inhibited. The movement recovered subsequent to releasing the drug indicating that the dynamic change of the actin cytoskeleton is extremely important to cell migration. Chen et al (20) identified that the change of cell adhesion is also closely connected with the change of actin. Therefore, certain investigators believe that the aggregation and disaggregation of intracellular actin can promote the migration of MCs (21).

The results of the present study show that when compared with the control group, 0.0375–0.3 mg/ml of the FLL extract can significantly improve the adhesion rate of MCs in a dose-dependent manner. In addition, 0.15 mg/ml of the FLL extract can significantly promote the migration of MCs. Oleanolic acid has no clear effect on the adhesion of MCs, and only 12 µM oleanolic acid promoted the migration of MCs. Compared with the control group, 40 µM quercetin significantly improved the cell adhesion; however, its affect on the migration of MCs was not clear. In addition, the actin in the MCs treated with 0.15 mg/ml of the FLL extract, 12 µM oleanolic acid and 40 µM quercetin exhibited an aggregation change at different levels. The stress fiber fasciculus is mainly distributed inside the cell membrane and around the nucleus. The MOD in these 3 groups was significantly higher compared to the control group. It is speculated that the FLL extract and its monomers oleanolic acid and quercetin can activate the precursor MCs in hair follicle reservoir, activate actin and induce the aggregation of cellular actin cytoskeleton. The monomers promote the cell adhesion and migration to the lesion position for the production of melanin and formation of pigment island surrounding the hair follicle. Oleanolic acid may be the active ingredient in the FLL extract, which promotes the MC migration, and quercetin may be the active ingredient in FLL, which enhances the adhesion of MCs. There may be another action mechanism of the FLL extract on MCs, which should be explored in future studies. In addition, in the present study the effects of oleanolic acid on the adhesion of MCs and the effects of quercetin on cell migration are not clear, which should be further investigated.

Acknowledgements

The present study was supported by a grant from Natural Science Foundation of Guangdong Province (no. 9151051501000006).

References

1 

Moretti S, Spallanzani A, Amato L, Hautmann G, Gallerani I, Fabiani M and Fabbri P: New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions. Pigment Cell Res. 15:87–92. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Yoshida H, Kunisada T, Grimm T, Nishimura EK, Nishioka E and Nishikawa SI: Review: Melanocyte migration and survival controlled by SCF/c-kit expression. J Investig Dermatol Symp Proc. 6:1–5. 2001. View Article : Google Scholar : PubMed/NCBI

3 

Vickaryous MK and Hall BK: Human cell type diversity, evolution, development, and classification with special reference to cells derived from the neural crest. Biol Rev Camb Philos Soc. 81:425–455. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Cheng M and Hu ZH: The Ligustrum biological and chemical composition of progress. Chin Tradit Herbal Drugs. 41:1219–1221. 2010.(In Chinese).

5 

Tian LT, Ma L and Du NS: Survey of pharmacology of oleanolic acid. Zhongguo Zhong Yao Za Zhi. 27:884–886, 901. 2002.(In Chinese). PubMed/NCBI

6 

Chouaïb K, Hichri F, Nguir A, Daami-Remadi M, Elie N, Touboul D, Ben Jannet H and Hamza MA: Semi-synthesis of new antimicrobial esters from the natural oleanolic and maslinic acids. Food Chem. 183:8–17. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Hoek-van den Hil EF, van Schothorst EM, van der Stelt I, Hollman PC, Keijer J and Rietjens IM: Quercetin tests negative for genotoxicity in transcriptome analyses of liver and small intestine of mice. Food Chem Toxicol. 81:34–39. 2015. View Article : Google Scholar : PubMed/NCBI

8 

Wiczkowski W, Szawara-Nowak D, Topolska J, et al: Metabolites of dietary quercetin: Profile, isolation, identification, and antioxidant capacity. J Funct Foods. 11:121–129. 2014. View Article : Google Scholar

9 

Cai LV and Zhang J: Pharmacological effects of the quercetin. World Phytomedicines. 20:108–112. 2005.(In Chinese).

10 

Liu ZL, Tu CX, Ren F and Lin XR: Research the role of the 56 herbs alcohol extract to tyrosinase activity and animals pigments. Chin J Dermatol. 34:284–285. 2001.(In Chinese).

11 

Chang SB, Xu AE, Li YW, Zhang DM and Wei XD: Effects of extracts from seven kinds of traditional Chinese medicine on the proliferation and melanogenesis of a melanocyte cell line B10BR by interaction with HaCaT cells. Chin J Dermatol. 40:409–411. 2007.(In Chinese).

12 

Zhang DM, Li YW, Wei XD and Xu AE: Effects of Fructus Ligustri Lucidi on the tyrosinase activity and melanogenesis of cultured human melanocytes. Chin J Dermatol. 39:197–199. 2006.(In Chinese).

13 

Takeyama R, Takekoshi S, Nagata H, Osamura RY and Kawana S: Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model. J Mol Histol. 35:157–165. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Nagata H, Takekoshi S, Takeyama R, Homma T and Yoshiyuki Osamura R: Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes. Pigment Cell Res. 17:66–73. 2004. View Article : Google Scholar : PubMed/NCBI

15 

Nylander K, Bourdon JC, Bray SE, Gibbs NK, Kay R, Hart I and Hall PA: Transcriptional activation of tyrosinase and TRP-1 by p53 links UV irradiation to the protective tanning response. J Pathol. 190:39–46. 2000. View Article : Google Scholar : PubMed/NCBI

16 

Plaumann B, Fritsche M, Rimpler H, Brandner G and Hess RD: Flavonoids activate wild-type p53. Oncogene. 13:1605–1614. 1996.PubMed/NCBI

17 

Ma HJ, Yue XZ, Wang DG, Li CR and Zhu WY: A modified method for purifying amelanotic melanocytes from human hair follicles. J Dermatol. 33:239–248. 2006. View Article : Google Scholar : PubMed/NCBI

18 

Cui J, Shen LY and Wang GC: Role of hair follicles in the repigmentation of vitiligo. J Invest Dermatol. 97:410–416. 1991. View Article : Google Scholar : PubMed/NCBI

19 

Miao L: Review: Cell movement, cell migration, and cytoskeletal research progress. Acta Biophys Sin. 23:281–288. 2007.(In Chinese).

20 

Chen HQ, Tian W, Chen YS, Li L, Raum J and Sung KL: Effect of steady and oscillatory shear stress on F-actin content and distribution in neutrophils. Biorheology. 41:655–664. 2004.PubMed/NCBI

21 

Wehrle-Haller B: The role of Kit-ligand in melanocyte development and epidermal homeostasis. Pigment Cell Res. 16:287–296. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wu Y, Li Q, Li X, He D, Niu M, Lu X and Li H: Effect of the Fructus Ligustri Lucidi extract and its monomers quercetin and oleanolic acid on the adhesion and migration of melanocytes and intracellular actin. Biomed Rep 4: 583-588, 2016.
APA
Wu, Y., Li, Q., Li, X., He, D., Niu, M., Lu, X., & Li, H. (2016). Effect of the Fructus Ligustri Lucidi extract and its monomers quercetin and oleanolic acid on the adhesion and migration of melanocytes and intracellular actin. Biomedical Reports, 4, 583-588. https://doi.org/10.3892/br.2016.638
MLA
Wu, Y., Li, Q., Li, X., He, D., Niu, M., Lu, X., Li, H."Effect of the Fructus Ligustri Lucidi extract and its monomers quercetin and oleanolic acid on the adhesion and migration of melanocytes and intracellular actin". Biomedical Reports 4.5 (2016): 583-588.
Chicago
Wu, Y., Li, Q., Li, X., He, D., Niu, M., Lu, X., Li, H."Effect of the Fructus Ligustri Lucidi extract and its monomers quercetin and oleanolic acid on the adhesion and migration of melanocytes and intracellular actin". Biomedical Reports 4, no. 5 (2016): 583-588. https://doi.org/10.3892/br.2016.638
Copy and paste a formatted citation
x
Spandidos Publications style
Wu Y, Li Q, Li X, He D, Niu M, Lu X and Li H: Effect of the Fructus Ligustri Lucidi extract and its monomers quercetin and oleanolic acid on the adhesion and migration of melanocytes and intracellular actin. Biomed Rep 4: 583-588, 2016.
APA
Wu, Y., Li, Q., Li, X., He, D., Niu, M., Lu, X., & Li, H. (2016). Effect of the Fructus Ligustri Lucidi extract and its monomers quercetin and oleanolic acid on the adhesion and migration of melanocytes and intracellular actin. Biomedical Reports, 4, 583-588. https://doi.org/10.3892/br.2016.638
MLA
Wu, Y., Li, Q., Li, X., He, D., Niu, M., Lu, X., Li, H."Effect of the Fructus Ligustri Lucidi extract and its monomers quercetin and oleanolic acid on the adhesion and migration of melanocytes and intracellular actin". Biomedical Reports 4.5 (2016): 583-588.
Chicago
Wu, Y., Li, Q., Li, X., He, D., Niu, M., Lu, X., Li, H."Effect of the Fructus Ligustri Lucidi extract and its monomers quercetin and oleanolic acid on the adhesion and migration of melanocytes and intracellular actin". Biomedical Reports 4, no. 5 (2016): 583-588. https://doi.org/10.3892/br.2016.638
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team